ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127 | -18.1% | 42,242 | +2.4% | 0.00% | – |
| Q2 2023 | $155 | +15.7% | 41,232 | +3.7% | 0.00% | – |
| Q1 2023 | $134 | -3.6% | 39,744 | +37.9% | 0.00% | – |
| Q4 2022 | $139 | -99.9% | 28,813 | +4.3% | 0.00% | – |
| Q3 2022 | $158,000 | -3.7% | 27,621 | +19.7% | 0.00% | – |
| Q2 2022 | $164,000 | -94.9% | 23,081 | -94.8% | 0.00% | – |
| Q1 2022 | $3,220,000 | -12.8% | 445,960 | +8.0% | 0.00% | – |
| Q4 2021 | $3,691,000 | -93.0% | 412,915 | -72.4% | 0.00% | -100.0% |
| Q3 2021 | $52,449,000 | +44.4% | 1,495,965 | -11.6% | 0.01% | +66.7% |
| Q2 2021 | $36,333,000 | -76.4% | 1,691,482 | -34.0% | 0.00% | -80.0% |
| Q1 2021 | $153,805,000 | +50.4% | 2,561,375 | +1.7% | 0.02% | +50.0% |
| Q4 2020 | $102,251,000 | – | 2,517,977 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |